James D Wethe MD - Torrance Plastic Surgeon Fillers and Relaxers/Injectables

"Incredibly gentle when injecting fillers and botox. Super caring and definitely tells the patient what to expect after the procedure. Excellent staff- they are just the best!"

Call to Schedule

Dermal Fillers & Relaxers

Dr. Wethe offeres a variety of versatile dermal fillers and relaxers for his patients. Please call the office at 310-784-8389 to schedule a consultation where you can discuss the different products and help decide which will be best for your specific needs.

Dermal/Gel Fillers...

Juvederm Voluma XC in the cheeks and chin approved by FDA Black woman 'Contour Confidently'

Defy Gravity (Defy Lines) with Juvederm XC injectable gel for moderate to severe facial wrinkles and folds and to temporarily add volume to the skin specifically around the nose and mouth.

Juvederm Family of Fillers photo - Smooth, Plump and Lift

Juvederm Vollure XC the first and only hyaluronic acid dermal filler FDA approved for the correction of moderate to severe lines, folds and wrinkles.

Relaxers...

3440 Lomita Boulevard, Suite 220, Torrance, CA 90505

Office: 310-784-8389 Fax: 310-784-8399 Email: drwethe@drwethe.com

Photo and link to Join Our Mailing List via Constant Contact

Web Site Accessibility Statement
James D Wethe, MD is committed to ensuring that our web site is accessible to everyone. If you have any questions or suggestions regarding the accessibility of this site, please contact us, as we are continually striving to improve the experience for all of our visitors.
Portable Document Format
Some documents on this website are produced in portable document format (PDF). In order to improve viewing of these files, please download the latest version of Adobe Reader, which is available for free at the Adobe web site.
Our goal is to adhere to the accepted guidelines and standards for accessibility and usability. To that end we have recently reviewed our entire website to identify non-compliant elements or documents and to bring them into compliance. We are continuing this process to ensure that the site remains up-to-date regarding updated guidelines.

April 2021